Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a mouse model of a type of rickets that does not cause hair loss.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

A rare ITGB6 gene variant causes intellectual disability, hair loss, and dental issues.

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

No clear link between androgen receptor variation and hair loss, but more research needed.

AGA affects many, progresses differently, and early treatment is crucial.

Higher DHT in male baldness may protect against prostate cancer.

The document concludes that anticonvulsants like phenytoin may cause skin reactions by affecting tryptophan metabolism and suggests researching vitamin levels in patients with drug reactions.

Most hair loss in children is caused by a few common conditions and is easy to diagnose, but rare types require careful evaluation.

A new compound shows promise as a topical treatment for hair loss.

Higher p63 and CD34 levels found in specific scalp areas may affect hair loss progression.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Frontal fibrosing alopecia shows increased inflammation and JAK-STAT pathway activity without reduced hair proteins.

Injecting triamcinolone into the eyebrow area may help eyelash regrowth in alopecia areata patients.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Oral cyclosporin doesn't stop hair loss.

Dissolvable microneedles with Ginsenoside Rg3 can help treat hair loss by improving drug delivery and stimulating hair growth.

Both treatments for alopecia areata showed similar modest effectiveness.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

A girl with severe hair loss saw hair regrowth after using cannabis.

Stress can cause a type of hair loss in mice lacking the CCHCR1 gene.

Omics techniques are needed to understand the scalp microbiome's role in alopecia areata for new treatments.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

The role of γδT-cells in causing alopecia areata remains unclear.